Nexavar and Cisplatin drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Nexavar (sorafenib tosylate) and Cisplatin (cisplatin). Common drug interactions include pleural effusion among females and palmar-plantar erythrodysaesthesia syndrome among males.
The phase IV clinical study analyzes what interactions people have when they take Nexavar and Cisplatin. It is created by eHealthMe based on reports of 134 people who take the same drugs from the FDA, and is updated regularly.
What is Nexavar?
Nexavar has active ingredients of sorafenib tosylate. It is often used in hepatocellular carcinoma. eHealthMe is studying from 23,250 Nexavar users. Check the latest studies of Nexavar.
What is Cisplatin?
Cisplatin has active ingredients of cisplatin. It is often used in chemotherapy. eHealthMe is studying from 92,837 Cisplatin users. Check the latest studies of Cisplatin.
134 people who take Nexavar and Cisplatin together, and have interactions are studied.
What are the common drug interactions of Nexavar and Cisplatin, by gender? *
What are the common drug interactions of Nexavar and Cisplatin, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Nexavar and Cisplatin?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Nexavar and Cisplatin:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Nexavar:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Cisplatin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Nexavar and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Cisplatin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Schlumbrecht MP, Hehr K, "Cisplatin-induced bradycardia and the importance of the QT interval", Journal of Oncology Pharmacy Practice, 2015 Jan .
- Schlumbrecht MP, Hehr K, "Cisplatin-induced bradycardia and the importance of the QT interval", Journal of Oncology Pharmacy Practice, 2015 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on sorafenib tosylate and cisplatin (the active ingredients of Nexavar and Cisplatin, respectively), and Nexavar and Cisplatin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Lemtrada and Rash Generalised for Women aged 20-29 - a second ago
- Lemtrada and Rash for Women aged 20-29 - a second ago
- Lemtrada and Skin Redness Or Inflammation for Women aged 20-29 - a second ago
- Lemtrada and Skin Rash for Women aged 20-29 - 2 seconds ago
- Lemtrada and Skin Lesion for Women aged 20-29 - 2 seconds ago
- Lemtrada and Rubor for Women aged 20-29 - 2 seconds ago
- Lemtrada and Erythema for Women aged 20-29 - 3 seconds ago
- Lemtrada and Rashes for Women aged 20-29 - 3 seconds ago
- Calcium Gluconate and Vitamin D drug interactions for women aged 50-59 - 4 seconds ago
- Shoulder Pain and Rotator Cuff Syndrome - 7 seconds ago